<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab — Januar 2022]]></title><description><![CDATA[<p dir="auto">Godt nytår og tak for al jeres input og viden , her på pro investor..</p>
]]></description><link>https://dev.proinvestor.com/forum/topic/399156/genmab-januar-2022</link><generator>RSS for Node</generator><lastBuildDate>Mon, 08 Jun 2026 10:34:03 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/399156.rss" rel="self" type="application/rss+xml"/><pubDate>Sat, 01 Jan 2022 09:51:28 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 20:04:59 GMT]]></title><description><![CDATA[<p dir="auto">Us fortsætter op. Igen incl nbi.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650023</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650023</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Mon, 31 Jan 2022 20:04:59 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 18:26:13 GMT]]></title><description><![CDATA[<p dir="auto">Bemærkede iøvrigt at de tre mest shortede firmaer i DK alle er biotek, men Genmab er slet ikke på listen, det opfatter jeg som posetivt <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=6f0fab7c92c" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> <a href="https://shortnordic.com/most_shorted_companies_all.php?country=denmark" rel="nofollow ugc">https://shortnordic.com/most_shorted_companies_all.php?country=denmark</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650022</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650022</guid><dc:creator><![CDATA[HHM]]></dc:creator><pubDate>Mon, 31 Jan 2022 18:26:13 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 18:22:46 GMT]]></title><description><![CDATA[<p dir="auto">Ja, Inga, syntes også det er lidt underligt, det har jo faktisk været en OK dag, til en forandring, uden den der siven hen over dagen. Der er stadig langt tilbage til 3100, eller de 4-5-6000 man talte om før da, MEN man håber da på en dag som denne at det dårlig momentum måske er vendt til posetivt momentum.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650018</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650018</guid><dc:creator><![CDATA[HHM]]></dc:creator><pubDate>Mon, 31 Jan 2022 18:22:46 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 18:11:46 GMT]]></title><description><![CDATA[<p dir="auto">Overraskende stille herinde i forhold til at ADS’en er 120kr over fredagens DK luk</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650019</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650019</guid><dc:creator><![CDATA[Inga_Finnsen]]></dc:creator><pubDate>Mon, 31 Jan 2022 18:11:46 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 16:04:52 GMT]]></title><description><![CDATA[<p dir="auto">Mandagens aktier: C25 badet i grønt med biotek og Vestas i front<br />
<a href="https://www.proinvestor.com/investornyt/773760/mandagens-aktier-c25-badet-i-gront-med-biotek-og-vestas-i-front" rel="nofollow ugc">https://www.proinvestor.com/investornyt/773760/mandagens-aktier-c25-badet-i-gront-med-biotek-og-vestas-i-front</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650016</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650016</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 31 Jan 2022 16:04:52 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 14:13:52 GMT]]></title><description><![CDATA[<p dir="auto">Genmab ligger sørme på 5. pladsen over de største skatteydere i 2021 <a href="https://finans.dk/erhverv/ECE13690430/her-er-danmarks-stoerste-skatteydere/?ctxref=ext" rel="nofollow ugc">https://finans.dk/erhverv/ECE13690430/her-er-danmarks-stoerste-skatteydere/?ctxref=ext</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650020</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650020</guid><dc:creator><![CDATA[Plimsoller]]></dc:creator><pubDate>Mon, 31 Jan 2022 14:13:52 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 12:21:15 GMT]]></title><description><![CDATA[<p dir="auto">Janssen Submits Marketing Authorisation Application to the European Medicines Agency Seeking Approval of Bispecific Antibody Teclistamab for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma <a href="https://www.businesswire.com/news/home/20220128005418/en/Janssen-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-Bispecific-Antibody-Teclistamab-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma" rel="nofollow ugc">https://www.businesswire.com/news/home/20220128005418/en/Janssen-Submits-Marketing-Authorisation-Application-to-the-European-Medicines-Agency-Seeking-Approval-of-Bispecific-Antibody-Teclistamab-for-the-Treatment-of-Patients-with-Relapsed-or-Refractory-Multiple-Myeloma</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650014</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650014</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Mon, 31 Jan 2022 12:21:15 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 11:52:58 GMT]]></title><description><![CDATA[<p dir="auto">undskyld "gammel nyhed"</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650013</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650013</guid><dc:creator><![CDATA[Doublo]]></dc:creator><pubDate>Mon, 31 Jan 2022 11:52:58 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 11:52:11 GMT]]></title><description><![CDATA[<p dir="auto">HC Wainwright co hæver kursen til køb fra neutral og deres kurs på Genmab er. 47$</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650012</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650012</guid><dc:creator><![CDATA[Doublo]]></dc:creator><pubDate>Mon, 31 Jan 2022 11:52:11 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 11:43:34 GMT]]></title><description><![CDATA[<p dir="auto">i said last week InnovaTV 205 was already combining with Keytruda , but not Keytruda and chemo together; they now add 1 arm to include that combo, possibly even a quad combination <a href="https://clinicaltrials.gov/ct2/history/NCT03786081?A=13&amp;B=14&amp;C=merged#StudyPageTop" rel="nofollow ugc">https://clinicaltrials.gov/ct2/history/NCT03786081?A=13&amp;B=14&amp;C=merged#StudyPageTop</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650011</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650011</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Mon, 31 Jan 2022 11:43:34 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 11:35:44 GMT]]></title><description><![CDATA[<p dir="auto">Daratumumab for treatment-refractory antibody-mediated diseases in neurology <a href="https://onlinelibrary.wiley.com/doi/10.1111/ene.15266" rel="nofollow ugc">https://onlinelibrary.wiley.com/doi/10.1111/ene.15266</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650015</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650015</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Mon, 31 Jan 2022 11:35:44 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 10:58:39 GMT]]></title><description><![CDATA[<p dir="auto"><img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f44d.png?v=6f0fab7c92c" class="not-responsive emoji emoji-android emoji--+1" style="height:23px;width:auto;vertical-align:middle" title="👍" alt="👍" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650009</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650009</guid><dc:creator><![CDATA[StockBull]]></dc:creator><pubDate>Mon, 31 Jan 2022 10:58:39 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 10:56:15 GMT]]></title><description><![CDATA[<p dir="auto"><img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=6f0fab7c92c" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650008</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650008</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Mon, 31 Jan 2022 10:56:15 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 10:51:51 GMT]]></title><description><![CDATA[<p dir="auto">Og de 47$ svarer til rundt regnet kurs 3.140 <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=6f0fab7c92c" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650017</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650017</guid><dc:creator><![CDATA[Darvin]]></dc:creator><pubDate>Mon, 31 Jan 2022 10:51:51 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 10:50:36 GMT]]></title><description><![CDATA[<p dir="auto">No change,<br />
still 47 USD</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650004</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650004</guid><dc:creator><![CDATA[nohope]]></dc:creator><pubDate>Mon, 31 Jan 2022 10:50:36 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 10:49:02 GMT]]></title><description><![CDATA[<p dir="auto">Genmab/HC Wainwright: ADR-notering hæves til "køb" fra "neutral"<br />
<a href="https://www.proinvestor.com/investornyt/773555/genmab-hc-wainwright-adr-notering-haeves-til-kob-fra-neutral" rel="nofollow ugc">https://www.proinvestor.com/investornyt/773555/genmab-hc-wainwright-adr-notering-haeves-til-kob-fra-neutral</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650003</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650003</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 31 Jan 2022 10:49:02 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 10:48:47 GMT]]></title><description><![CDATA[<p dir="auto">$47, same as they had before i think</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650007</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650007</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Mon, 31 Jan 2022 10:48:47 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 10:33:03 GMT]]></title><description><![CDATA[<p dir="auto">H.C. Wainwright analyst Raghuram Selvaraju upgraded Genmab to Buy -I can't see if there is a new PT</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650006</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650006</guid><dc:creator><![CDATA[E_L]]></dc:creator><pubDate>Mon, 31 Jan 2022 10:33:03 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 09:54:38 GMT]]></title><description><![CDATA[<p dir="auto">Aktier/middag: C25-rutsjebaneturen fortsætter med biotek i topform<br />
<a href="https://www.proinvestor.com/investornyt/773530/aktier-middag-c25-rutsjebaneturen-fortsaetter-med-biotek-i-topform" rel="nofollow ugc">https://www.proinvestor.com/investornyt/773530/aktier-middag-c25-rutsjebaneturen-fortsaetter-med-biotek-i-topform</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650021</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650021</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 31 Jan 2022 09:54:38 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 08:10:54 GMT]]></title><description><![CDATA[<p dir="auto">Aktier/åbning: C25 helt i grønt - forsikringsselskaber slipper billigt<br />
<a href="https://www.proinvestor.com/investornyt/773502/aktier-abning-c25-helt-i-gront-forsikringsselskaber-slipper-billigt" rel="nofollow ugc">https://www.proinvestor.com/investornyt/773502/aktier-abning-c25-helt-i-gront-forsikringsselskaber-slipper-billigt</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650010</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650010</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 31 Jan 2022 08:10:54 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 07:28:49 GMT]]></title><description><![CDATA[<p dir="auto">Det er store biotek-dag i dag. Bava, gen og zeal strides om topplaceringen.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650002</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650002</guid><dc:creator><![CDATA[Bulder]]></dc:creator><pubDate>Mon, 31 Jan 2022 07:28:49 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 06:52:32 GMT]]></title><description><![CDATA[<p dir="auto">Tak. Kan anbefale chatgruppen for "aktiesnakken" eller "debat-området", hvor der kan føres mere generelle indlæg, som ikke nødvendigvis rammer Genmab chatten spot on <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f609.png?v=6f0fab7c92c" class="not-responsive emoji emoji-android emoji--wink" style="height:23px;width:auto;vertical-align:middle" title=";-)" alt="😉" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650001</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650001</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Mon, 31 Jan 2022 06:52:32 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 06:48:56 GMT]]></title><description><![CDATA[<p dir="auto">Tsk-tsk ,.. lige over ,.. se evt på muligheden i en dybere bund istedet for sarkasmen <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=6f0fab7c92c" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7650000</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7650000</guid><dc:creator><![CDATA[HHM]]></dc:creator><pubDate>Mon, 31 Jan 2022 06:48:56 GMT</pubDate></item><item><title><![CDATA[Reply to Genmab — Januar 2022 on Mon, 31 Jan 2022 06:42:20 GMT]]></title><description><![CDATA[<p dir="auto">Godmorgen. Tak for bidraget <a class="plugin-mentions-user plugin-mentions-a" href="/forum/user/hhm" aria-label="Profile: HHM">@<bdi>HHM</bdi></a> - tillader mig, at linke til support siden for <a href="http://Proinvestor.com" rel="nofollow ugc">Proinvestor.com</a>, hvor man også kan bidrage <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=6f0fab7c92c" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /> <a href="https://www.proinvestor.com/donation" rel="nofollow ugc">https://www.proinvestor.com/donation</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7649999</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7649999</guid><dc:creator><![CDATA[deleted-user]]></dc:creator><pubDate>Mon, 31 Jan 2022 06:42:20 GMT</pubDate></item></channel></rss>